These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38154590)

  • 21. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC; Parker D; Rollema H; Mead AN
    Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varenicline rescues nicotine-induced decrease in motivation for sucrose reinforcement.
    Hart E; Hertia D; Barrett ST; Charntikov S
    Behav Brain Res; 2021 Jan; 397():112887. PubMed ID: 32931838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
    Cunningham CS; McMahon LR
    Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
    George O; Lloyd A; Carroll FI; Damaj MI; Koob GF
    Psychopharmacology (Berl); 2011 Feb; 213(4):715-22. PubMed ID: 20924754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
    Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
    King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
    Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
    Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
    Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the interoceptive stimulus effects of nicotine and varenicline.
    Thompson BM; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2019 Jun; 181():9-16. PubMed ID: 30954637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.
    Rollema H; Russ C; Lee TC; Hurst RS; Bertrand D
    Nicotine Tob Res; 2014 Jun; 16(6):733-42. PubMed ID: 24406270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
    Palmatier MI; Levin ME; Mays KL; Donny EC; Caggiula AR; Sved AF
    Psychopharmacology (Berl); 2009 Dec; 207(3):381-90. PubMed ID: 19760281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB; McMahon LR
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
    Rollema H; Shrikhande A; Ward KM; Tingley FD; Coe JW; O'Neill BT; Tseng E; Wang EQ; Mather RJ; Hurst RS; Williams KE; de Vries M; Cremers T; Bertrand S; Bertrand D
    Br J Pharmacol; 2010 May; 160(2):334-45. PubMed ID: 20331614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.
    Cunningham CS; Moerke MJ; Javors MA; Carroll FI; McMahon LR
    Br J Pharmacol; 2016 Dec; 173(24):3454-3466. PubMed ID: 27667659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats.
    Guy EG; Fisher DC; Higgins GA; Fletcher PJ
    Behav Pharmacol; 2014 Dec; 25(8):775-83. PubMed ID: 25230208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of acquisition learning on nicotine and varenicline drug substitution in a drug-discriminated goal-tracking task.
    Thompson BM; Barrett ST; Huynh YW; Kwan DA; Murray JE; Bevins RA
    Pharmacol Biochem Behav; 2020 Dec; 199():173045. PubMed ID: 33058788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
    Rollema H; Hajós M; Seymour PA; Kozak R; Majchrzak MJ; Guanowsky V; Horner WE; Chapin DS; Hoffmann WE; Johnson DE; McLean S; Freeman J; Williams KE
    Biochem Pharmacol; 2009 Oct; 78(7):813-24. PubMed ID: 19501054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine.
    Palmatier MI; Liu X; Caggiula AR; Donny EC; Sved AF
    Neuropsychopharmacology; 2007 May; 32(5):1098-108. PubMed ID: 17091131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.
    Levin ME; Weaver MT; Palmatier MI; Caggiula AR; Sved AF; Donny EC
    Nicotine Tob Res; 2012 Mar; 14(3):299-305. PubMed ID: 21994342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.